Product logins

Find logins to all Clarivate products below.


Anne Lecocq

Senior Vice President and General Manager, Research & Development

Anne Lecocq is a seasoned life sciences executive with over 20 years of experience. She began her career in the pharmaceutical and generics industries, specializing in regulatory compliance and chemistry, manufacturing and controls (CMC), before joining Clarivate in 2008.

At Clarivate, Anne has held multiple leadership roles overseeing data and content strategy for Cortellis solutions spanning drug discovery, clinical trials, competitive intelligence, safety, and regulatory intelligence. In her current role as General Manager of the R&D Business, she drives product innovation and strategic growth for the Cortellis product suite, enabling biopharma organizations to accelerate the delivery of life-changing therapies to patients through actionable intelligence and advanced analytics.

Anne holds dual master’s degrees in Biotechnology & Chemistry and Regulatory Affairs. Based in Paris, France, she is passionate about leveraging her multidisciplinary expertise to advance global R&D efficiency through transformative intelligence.

Latest news

News October 14, 2025
Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program

89 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 London, U.K. October 14, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of…

News October 7, 2025
Winbond Selects IPfolio from Clarivate

Global Electronics Manufacturer to Modernize IP Management and Drive Digital Transformation London, U.K. October 7, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that…

News October 6, 2025
Clarivate to Report Third Quarter 2025 Results on October 29, 2025

London, U.K., October 6, 2025 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025